Concepedia

An open label, single-arm, phase II multicenter study of the safety and efficacy of CG0070 oncolytic vector regimen in patients with BCG-unresponsive non–muscle-invasive bladder cancer: Interim results

Vignesh T. Packiam, Donald L. Lamm, Daniel A. Barocas, Andrew Trainer, Benjamin Fand, Ronald L. Davis, William R. Clark, Michael Kroeger, Igor Dumbadze, Karim Chamie,

Urologic Oncology Seminars and Original Investigations · 2017 · 243 citations · 16 references

DOI

Concepts

References

16

EAU Guidelines on Non–Muscle-invasive Urothelial Carcinoma of the Bladder: Update 2016

Marko Babjuk, Andreas Böhle, Maximilian Burger et al. · European Urology · 2016 · 2.3K citations

, , +16

Detrusor Muscle in the First, Apparently Complete Transurethral Resection of Bladder Tumour Specimen Is a Surrogate Marker of Resection Quality, Predicts Risk of Early Recurrence, and Is Dependent on Operator Experience

Paramananthan Mariappan, Alexandra Zachou, Kenneth M. Grigor · European Urology · 2009 · 350 citations

, , +15

EFFICACY AND SAFETY OF VALRUBICIN FOR THE TREATMENT OF BACILLUS CALMETTE-GUERIN REFRACTORY CARCINOMA IN SITU OF THE BLADDER

Gary D. Steinberg, Robert Bahnson, Stanley A. Brosman et al. · The Journal of Urology · 2000 · 340 citations

, , +6

Bladder Cancer

Peter E. Clark, Neeraj Agarwal, Matthew C. Biagioli et al. · Journal of the National Comprehensive Cancer Network · 2013 · 313 citations · Full text

, , +17

Final results from a national multicenter phase II trial of combination bacillus Calmette-Guérin plus interferon α-2B for reducing recurrence of superficial bladder cancer☆

Fadi N. Joudi, Michael A. O’Donnell · Urologic Oncology Seminars and Original Investigations · 2006 · 243 citations

, , +7